Warning letterFDA · Aug 25, 2020
Renewal Supplements LLC MARCS-CMS 608749, August 25, 2020
Named company: Renewal Supplements LLC
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, “Opi-Cure” fails to bear adequate directions…
Lot information: not specified in this record.